Ganesh, Karuna
Wu, Chao
O’Rourke, Kevin P.
Szeglin, Bryan C. http://orcid.org/0000-0002-7866-7548
Zheng, Youyun
Sauvé, Charles-Etienne Gabriel
Adileh, Mohammad
Wasserman, Isaac
Marco, Michael R.
Kim, Amanda S.
Shady, Maha
Sanchez-Vega, Francisco
Karthaus, Wouter R.
Won, Helen H.
Choi, Seo-Hyun
Pelossof, Raphael
Barlas, Afsar
Ntiamoah, Peter
Pappou, Emmanouil
Elghouayel, Arthur
Strong, James S.
Chen, Chin-Tung
Harris, Jennifer W.
Weiser, Martin R.
Nash, Garrett M.
Guillem, Jose G.
Wei, Iris H.
Kolesnick, Richard N.
Veeraraghavan, Harini http://orcid.org/0000-0002-4054-5529
Ortiz, Eduardo J.
Petkovska, Iva
Cercek, Andrea
Manova-Todorova, Katia O.
Saltz, Leonard B.
Lavery, Jessica A. http://orcid.org/0000-0002-2746-5647
DeMatteo, Ronald P.
Massagué, Joan
Paty, Philip B.
Yaeger, Rona
Chen, Xi
Patil, Sujata
Clevers, Hans http://orcid.org/0000-0002-3077-5582
Berger, Michael F.
Lowe, Scott W. http://orcid.org/0000-0002-5284-9650
Shia, Jinru http://orcid.org/0000-0002-4351-2511
Romesser, Paul B.
Dow, Lukas E.
Garcia-Aguilar, Julio http://orcid.org/0000-0003-2451-0948
Sawyers, Charles L. http://orcid.org/0000-0003-4955-6475
Smith, J. Joshua http://orcid.org/0000-0003-2538-5456
Article History
Received: 3 December 2018
Accepted: 15 August 2019
First Online: 7 October 2019
Competing interests
: J.J.S. has received travel support from Intuitive Surgical Inc. and has served as a clinical advisor for Guardant Health, Inc. C.L.S. serves on the Board of Directors of Novartis, is a co-founder of ORIC Pharm and co-inventor of enzalutamide and apalutamide. He is a science advisor to Agios, Beigene, Blueprint, Column Group, Foghorn, Housey Pharma, Nextech, KSQ Therapeutics, Petra and PMV Pharma. He was a co-founder of Seragon, purchased by Genentech/Roche in 2014. J.M. is a science advisor and owns company stock in Scholar Rock. H.C. is an inventor on several patents related to organoid technology. S.W.L. is a co-founder and scientific advisory board member for ORIC Pharmaceuticals, Blueprint and Mirimus. He also serves on the scientific advisory board for Constellation, Petra and PMV and has recently served as a consultant for Forma, Boehringer Ingelheim and Aileron. J.G.-A. has received support from Medtronic (honorarium for consultancy with Medtronic), Johnson & Johnson (honorarium for delivering a talk) and Intuitive Surgical (honorarium for participating in a webinar by Intuitive Surgical). P.B.R. has received honorarium from Corning to discuss 3D cell culture techniques), has served as a consultant for AstraZeneca and is a consultant for EMD Serono for work on radiation sensitizers. R.N.K. is a cofounder of Ceramedix Holding, LLC. He also has patents unrelated to this work: R.N.K. (US7195775B1, US7850984B2, and US10052387B2), R.N.K. (US8562993B2, US9592238B2, US20150216971A1, and US20170335014A1) and R.N.K. (US20170333413A1 and US20180015183A1). K.P.O. has received an honorarium from Merck for discussing organoid platforms.